Pricing Log in Create free account

Allurion Technologies, Inc. (ALUR) vs HeartSciences Inc. (HSCS)

Allurion Technologies, Inc. and HeartSciences Inc. are both Medical Devices companies. Allurion Technologies, Inc. is the larger, with a market value of $16.7M against $13.3M — 1.3× the size. HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against −55.5%. Allurion Technologies, Inc. has the higher net margin (−264.7% vs −48,621.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Allurion Technologies, Inc. leads on 11 and HeartSciences Inc. on 2.

Valuation

Metric ALUR HSCS Medical Devices median
P/E n/m n/m 24.94
P/S n/m 488.61 2.66
P/B n/m n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 5.25 519.02 2.76
Earnings yield 0.00% (114.59%) (12.66%)
Free cash flow yield 0.00% (69.02%) (7.18%)

Profitability

Metric ALUR HSCS Medical Devices median
Gross margin 52.70% 18.01% 57.76%
Operating margin (211.21%) (44,918.48%) (14.84%)
Net margin (264.74%) (48,621.80%) (14.45%)
Free cash flow margin (180.19%) (33,725.12%) (5.70%)
Return on equity 45.16% (1,854.69%) (10.56%)
Return on assets (127.26%) (201.67%) (17.26%)
Return on invested capital 0.00% 0.00% (5.22%)

Growth

Metric ALUR HSCS Medical Devices median
Revenue growth (TTM) (55.49%) 131.87% 10.41%
EPS growth (last fiscal year) (18.97%) 62.74% 28.17%
Revenue growth, 5-year CAGR — (30.01%) 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALUR HSCS Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 0.30 0.14 2.67
Net debt to EBITDA 0.19 0.21 0.54

Dividend

Metric ALUR HSCS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric ALUR HSCS Medical Devices median
Market cap 16.70m 13.26m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack